Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma—Possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: Report of the radiation therapy oncology group protocol 8302-Reference-Cited by-同舟云学术

Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma—Possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: Report of the radiation therapy oncology group protocol 8302

Published:1993-01 Issue:2 Volume:25 Page:193-207
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Nelson Diana Furst,Curran Walter J.,Scott Charles,Nelson James S.,Weinstein Alan S.,Ahmad Khurshid,Constine Louis S.,Murray Kevin,Powlis William D.,Mohiuddin Mohammed,Fischbach Jennifer

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference26 articles.

1. Intracranial tumors: Response and resistance to therapeutic endeavors, 1970–1980;Bloom;Int. J. Radiat. Oncol. Biol. Phys.,1982

2. Surgical pathology of the nervous system and its coverings;Burger,1976

3. Regression models and life tables;Cox;J. Royal Stat. Soc. Series B,1972

4. A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma: report of Radiation Therapy Oncology Group 83-11.

5. Interfraction interval is major determinant of late effects, but not acute effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: Results from Radiation Therapy Oncology Group Protocol 83-13;Cox;Int. J. Radiat. Oncol. Biol. Phys.,1991

Cited by 152 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mathematical model of cancer with radiotherapy and chemotherapy treatments;Applicable Analysis;2024-05-17

2. Radiosensitization of IDH-Mutated Gliomas through ZMYND8 – a Pathway to Improved Outcomes;Clinical Cancer Research;2023-02-24

3. Gene Therapy for High Grade Glioma: The Clinical Experience;Expert Opinion on Biological Therapy;2022-12-16

4. A new approach to delineating clinical target volume for radiotherapy of glioblastoma: A phase II trial;Frontiers in Oncology;2022-10-19

5. Improving control of high‐grade glioma by ultra‐hyper‐fractionated radiotherapy;Journal of Neuroscience Research;2022-02-20